Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad Halwani, Christopher R. Flowers, Carlos Panizo et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 20
Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular LymphomaChristopher R. Flowers, Ahmad Halwani, Carlos Panizo et al.|Blood|2018Cited by 7
Intratumoral G100 to induce systemic immune responses and abscopal tumor regression in patients with follicular lymphoma.Christopher R. Flowers, Ahmad Halwani, Iris Isufi et al.|Journal of Clinical Oncology|2017Cited by 2
Abstract 5230: Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemiaQimei Han, Huidong Shi, Roni J. Bollag et al.|Cancer Research|2019Cited by 1
Abstract 5230: Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemiaQimei Han, Huidong Shi, Jianbo Wang et al.|Molecular and Cellular Biology / Genetics|2019Cited by 0